These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9517663)

  • 1. Severe symptomatic sinus bradycardia associated with mesalamine use.
    Asirvatham S; Sebastian C; Thadani U
    Am J Gastroenterol; 1998 Mar; 93(3):470-1. PubMed ID: 9517663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced bradycardia.
    Gn D; Patil M; Shafiq S
    Clin Med (Lond); 2023 Mar; 23(2):173-174. PubMed ID: 36958845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalamine-associated thrombocytopenia.
    Farrell RJ; Peppercorn MA; Fine SN; Michetti P
    Am J Gastroenterol; 1999 Aug; 94(8):2304-6. PubMed ID: 10445572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mesalamine-induced hypersensitivity pneumonitis].
    Zamir D; Weizman J; Zamir C; Fireman Z; Weiner P
    Harefuah; 1999 Jul; 137(1-2):28-30, 87, 86. PubMed ID: 10959271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.
    Actis GC; Ottobrelli A; Baldi S; Scappaticci E; Modena V; Fusaro E; Mengozzi G; Rizzetto M
    Mt Sinai J Med; 2005 Mar; 72(2):136-40. PubMed ID: 15770345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesalamine-induced chest pain: a case report.
    Amin HE; Della Siega AJ; Whittaker JS; Munt B
    Can J Cardiol; 2000 May; 16(5):667-9. PubMed ID: 10833545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
    Kundu A; Fitzgibbons TP
    J Med Case Rep; 2015 Sep; 9():216. PubMed ID: 26400725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalamine enema-induced exacerbation of ulcerative colitis.
    Bousseaden A; Ajana FZ; Essamri W; Benelbarhdadi I; Afifi R; Benazzouz M; Essaid A
    Int J Colorectal Dis; 2009 Nov; 24(11):1359-60. PubMed ID: 19444457
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for severe bradycardia during oral clonidine therapy for hypertension.
    Byrd BF; Collins HW; Primm RK
    Arch Intern Med; 1988 Mar; 148(3):729-33. PubMed ID: 3341873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis.
    Stelts S; Taylor MH; Nappi J; Van Bakel AB
    Ann Pharmacother; 2008 Jun; 42(6):904-5. PubMed ID: 18430794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Marked bradycardia during anesthetic induction treated with temporary cardiac pacing in a patient with latent sick sinus syndrome].
    Murakawa T; Ishihara H; Matsuki A
    Masui; 2001 Jan; 50(1):65-8. PubMed ID: 11211756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD; Woseth DM; Thisted RA; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalamine-Associated Sinus Bradycardia.
    Odofin A; Wanogho J; Elsadany M; Kostela J; Mattana J
    Am J Ther; 2019; 26(6):e763-e764. PubMed ID: 30883396
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradoxical effect of isoprenaline infusion.
    Brembilla-Perrot B; Muhanna I; Nippert M; Popovic B; Beurrier D; Houriez P; Terrier de la Chaise A; Claudon O; Louis P; Abdelaal A; State S; Andronache M; Suty-Selton C
    Europace; 2005 Nov; 7(6):621-7. PubMed ID: 16216767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.